Compare MNPR & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNPR | HNST |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.4M | 492.4M |
| IPO Year | 2019 | 2021 |
| Metric | MNPR | HNST |
|---|---|---|
| Price | $70.28 | $4.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $130.17 | $5.31 |
| AVG Volume (30 Days) | 127.0K | ★ 2.5M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.99 | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $371,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.17 |
| P/E Ratio | ★ N/A | $4.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.07 | $2.07 |
| 52 Week High | $124.82 | $6.01 |
| Indicator | MNPR | HNST |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 41.49 |
| Support Level | $66.88 | $3.22 |
| Resistance Level | $75.33 | $5.39 |
| Average True Range (ATR) | 4.74 | 0.31 |
| MACD | 0.73 | 0.00 |
| Stochastic Oscillator | 51.81 | 22.07 |
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.